Steroid derivative and application thereof

A technology of derivatives and steroids, applied in the field of organic compounds, can solve the problems of restricting the application of glucocorticoids, and achieve the effect of relieving colonic inflammation

Inactive Publication Date: 2021-09-17
SOUTHERN MEDICAL UNIVERSITY
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, systemic side effects caused by gastrointestinal absorption, such as opportunistic infections, diabetes, and osteoporosis, limit the application of glucocorticoids

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Steroid derivative and application thereof
  • Steroid derivative and application thereof
  • Steroid derivative and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] Embodiment 1 (preparation of compound)

[0019] The steroidal derivative described in this example consists of the following steps:

[0020] step one:

[0021] Dissolve 2.1g of sodium hydroxide in 18mL of water, add 2.88g of bromine dropwise in an ice bath, and when the bromine is completely dissolved, add the mixture to 12mL of dioxane to obtain a mixture; take the mixture and add 1.44g of pregnenolone acetic acid A solution of ester (1) (a mixed solution of 56 mL of dioxane and 16 mL of water), was stirred overnight, then sodium sulfite was added, heated to reflux until the solid was completely dissolved, and a white solid was precipitated after acidification with hydrochloric acid, and the solid was washed with water until the solution was colorless.

[0022] The chemical reaction formula of above-mentioned step 1 is as follows:

[0023]

[0024] The obtained white solid was identified by nuclear magnetic resonance spectrum, and the identification result was: 1H...

Embodiment 2

[0030] Embodiment 2 (cell experiment research)

[0031] 1. The purpose and principle of the experiment

[0032] Experimental purpose: The NO inhibition test was used to detect the inhibitory effect of a series of steroids synthesized on the production of NO by LPS-stimulated macrophages.

[0033] Experimental principle: NO is easily oxidized in vivo or in aqueous solution to generate NO 2 - , under acidic conditions, NO 2 - Diazonium reaction with diazonium salt sulfonamide, and generate diazo compound, the latter further reacts with naphthyl vinyl diamine, the product concentration of this reaction is the same as that of NO 2 - The concentration has a linear relationship, and there is a maximum absorption peak at 540nm-560nm.

[0034] 2. Basic information of reagents

[0035] Reagent name brand NaNO 2

Macklin N-1-Naphthylethylenediamine hydrochloride Macklin 4-aminobenzenesulfonic acid Macklin RPMI-1640 Basal Medium Gibco ...

Embodiment 3

[0061] Embodiment 3 (animal experiment research)

[0062] 1. Animal model

[0063] In the development of new drugs for inflammatory bowel disease, the dextran sodium sulfate (Dextran Sulfate Sodium Salt, DSS)-induced colitis (ulcerative colitis, UC) model is most widely used. By giving mice free to drink different concentrations of DSS aqueous solution, according to the time and cycle of medication, two colitis models, acute and chronic, can be established. The symptoms of this model are very similar to those of human UC, mainly manifested as diarrhea, mucoid stool, fecal occult blood, gross bloody stool, weight loss, decreased activity, and poor coat color. The main manifestations of the chronic phase colitis model are obvious shortening of the colon, thickening of the mucosa, enlargement of the lymph nodes, loss of goblet cells and loss of crypts, and a small number of animals have adenomatous polyps and tumor-like changes. The acute stage colitis model mainly manifests co...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a steroid derivative, the chemical structure of the derivative is shown in the following formula (I), and the steroid derivative has anti-inflammatory biological activity, significantly inhibits NO induced by LPS in RAW264.7 cells, and shows an obvious effect of relieving colitis in mice.

Description

technical field [0001] The invention relates to organic compounds, in particular to steroid derivatives, which can be used to prepare medicines for treating inflammatory enteritis. Background technique [0002] Inflammatory bowel disease (Inflammatory Bowel Diseases, IBD) is a type of autoimmune disease that occurs frequently in humans. The clinical manifestations are repeated abdominal pain, diarrhea, abdominal mass, mucus and bloody stool, intestinal obstruction, intestinal perforation, and weight loss. With the rising incidence in western countries, inflammatory bowel disease has become an important disease affecting human health. According to the pathological features and the location of the disease, it can be divided into ulcerative colitis (Ulcerative colitis, UC) and Crohn's disease (Crohn's disease, CD). When intestinal homeostasis is out of balance, intestinal mucosal permeability increases, resulting in impaired intestinal mucosal barrier function, which mediates ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07J43/00A61P1/00A61P29/00A61K31/58
CPCC07J43/003A61P1/00A61P29/00
Inventor 陈建军陈镜玄李玲
Owner SOUTHERN MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap